|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7,434.00 JPY | -1.33% |
|
-1.54% | -9.81% |
| 06-15 | Goldman Sachs Upgrades Chugai Pharmaceutical to Buy from Neutral; Price Target is 8,950 Yen | MT |
| 05-26 | Major Asian Stock Markets Fall Amid Renewed Middle East Tensions | MT |
| Market Cap | 12,399B 76.71B 67.38B 62.08B 58.04B 109B 7,238B 111B 745B 288B 3,568B 288B 282B | P/E 2026 * |
24.4x | P/E 2027 * | 20.9x |
|---|---|---|---|---|---|
| Enterprise Value | 11,477B 71B 62.37B 57.46B 53.73B 101B 6,699B 103B 689B 267B 3,302B 267B 261B | EV / Sales 2026 * |
8.27x | EV / Sales 2027 * | 7.32x |
| Free-Float |
38.12% | Yield 2026 * |
1.81% | Yield 2027 * | 2.08% |
Last Transcript: Chugai Pharmaceutical Co., Ltd.
| 1 day | -1.33% | ||
| 1 week | -1.54% | ||
| Current month | -5.80% | ||
| 1 month | -2.00% | ||
| 3 months | -12.03% | ||
| 6 months | -11.61% | ||
| Current year | -9.81% |
| 1 week | 7,434 |  | 7,596 |
| 1 month | 7,270 | | 7,964 |
| Current year | 7,270 | | 10,700 |
| 1 year | 5,942 | | 10,700 |
| 3 years | 3,767 | | 10,700 |
| 5 years | 3,191 | | 10,700 |
| 10 years | 1,003.33 | | 10,700 |
| Manager | Title | Age | Since |
|---|---|---|---|
Osamu Okuda
CEO | Chief Executive Officer | 63 | 2021-02-28 |
Iwaaki Taniguchi
DFI | Director of Finance/CFO | 59 | 2024-03-27 |
Kazuhiko Nishi
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Osamu Okuda
BRD | Director/Board Member | 63 | 2020-02-29 |
Iwaaki Taniguchi
BRD | Director/Board Member | 59 | 2024-03-27 |
| Director/Board Member | 51 | 2025-02-28 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.33% | -1.54% | -1.96% | +77.00% | 76.71B | |
| +0.93% | +2.65% | +42.33% | +145.77% | 1,006B | |
| +1.61% | +7.22% | +60.81% | +47.98% | 589B | |
| +3.51% | +12.31% | +31.15% | +78.88% | 430B | |
| -1.28% | +5.11% | +29.26% | +21.27% | 331B | |
| -0.76% | +5.50% | +37.64% | +23.65% | 288B | |
| -1.55% | +4.82% | +29.14% | +39.45% | 285B | |
| -2.46% | +5.00% | -28.62% | -42.77% | 213B | |
| +0.40% | +4.51% | +25.85% | +55.35% | 190B | |
| -1.05% | +0.06% | +16.91% | +59.86% | 154B | |
| Average | -0.73% | +5.32% | +24.25% | +50.64% | 356.25B | |
| Weighted average by Cap. | -0.52% | +5.25% | +34.22% | +70.29% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1,387B 8.58B 7.54B 6.94B 6.49B 12.18B 810B 12.4B 83.32B 32.27B 399B 32.22B 31.52B | 1,535B 9.5B 8.34B 7.69B 7.19B 13.48B 896B 13.73B 92.21B 35.72B 442B 35.66B 34.88B |
| Net income | 509B 3.15B 2.76B 2.55B 2.38B 4.47B 297B 4.55B 30.56B 11.84B 146B 11.82B 11.56B | 593B 3.67B 3.22B 2.97B 2.78B 5.21B 346B 5.3B 35.63B 13.8B 171B 13.78B 13.48B |
| Net Debt | -923B -5.71B -5.01B -4.62B -4.32B -8.1B -539B -8.25B -55.42B -21.47B -265B -21.43B -20.96B | -1,166B -7.21B -6.33B -5.84B -5.46B -10.23B -680B -10.42B -70.02B -27.12B -335B -27.08B -26.49B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-06-26 | JP¥7,434.00 | -1.33% | 2,058,200 |
| 26-06-25 | JP¥7,534.00 | +0.45% | 1,882,900 |
| 26-06-24 | JP¥7,500.00 | +0.89% | 1,977,300 |
| 26-06-23 | JP¥7,434.00 | -1.17% | 2,411,300 |
| 26-06-22 | JP¥7,522.00 | -0.37% | 1,238,100 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 4519 Stock
Select your edition
All financial news and data tailored to specific country editions
